Jun 08, 2020
Akcea announces approval for reimbursement of TEGSEDI® (inotersen) in Italy for treatment of hereditary transthyretin amyloidosis with polyneuropathy
Jun 02, 2020
Seattle Plastic Surgeon Uses Human Donated Placenta To Grow Hair
May 26, 2020
Sexton Biotechnologies and Ikeda Scientific Provide Human Platelet Lysate to Japanese Regenerative Medicine Product Manufacturers
May 14, 2020
Cellphire Announces Orphan Drug Designation of Thrombosomes® for Treatment of Acute Radiation Syndrome
May 14, 2020
The Global Platelet Rich Plasma Market is expected to grow from USD 210.30 Million in 2018 to USD 489.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.81%
May 13, 2020
Global Plasma Therapy Market is Anticipated to Register for $432.8 Million by 2026 Despite COVID-19 Pandemic - Research Dive
May 11, 2020
Impact on Global Plasma Therapy Market in Wake of COVID-19 Pandemic
Apr 30, 2020
China National Medical Products Administration Approves DOPTELET® (avatrombopag) for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure
Mar 30, 2020
Extracellular Vesicles From Plasma Have Higher Tumor RNA Fraction Than Platelets
Mar 18, 2020
Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients
Mar 10, 2020
Red Cross Urges Healthy Individuals to Give Blood amid Coronavirus Concerns
Feb 25, 2020
EmCyte Announces FDA 510(k) Clearance for its PurePRP® Supraphysiologic Concentrating System
Feb 20, 2020
EmCyte Announces the Acquisition of the Centrepid Platelet Concentrator
Feb 10, 2020
Global Apheresis Market Report 2020 with Industry Forecasts to 2025 - Increasing Demand for Source Plasma from Biopharmaceutical Companies, Increase in the Number of Complex Surgical Procedures
Jan 24, 2020
Crown Aesthetics Announces Addition Of ProGen PRP(TM) Advantage To ProGen PRP Portfolio
Jan 13, 2020
Dova Granted Orphan Drug Designation for Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia
Jan 06, 2020
Critical Shortage of Blood and Blood Components
Jan 06, 2020
Growth Supplement Boosts CAR-T Cell Performance - Sexton Biotechnologies Releases T-Cell Specific Human Platelet Lysate
Dec 09, 2019
Additional Analyses From Phase 3 study With Doptelet ® (avatrombopag) for the treatment of Chronic Immune Thrombocytopenia Provides Evidence of Long-term Response Rates
Dec 09, 2019
Doptelet ® (avatrombopag) Demonstrates Cost-effectiveness for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease